Clinical Trial Update: RAPA-501 Therapy for ALS [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating RAPA-501 therapy for amyotrophic lateral sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• RAPA-501

Snippet

Sponsor: Rapa Therapeutics LLC | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: RECRUITING